A5019022239- Nanoparticle-Based Drug Delivery
- Nanoplatforms for cancer theranostics
- Cancer-related molecular mechanisms research
- Synthesis of Tetrazole Derivatives
- Extracellular vesicles in disease
- Hemoglobin structure and function
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Multiple Myeloma Research and Treatments
- RNA Research and Splicing
- Cancer Mechanisms and Therapy
- MicroRNA in disease regulation
- Lymphoma Diagnosis and Treatment
- Synthesis and bioactivity of alkaloids
- Synthesis and biological activity
The First People's Hospital of Wenling
2021-2022
Shanghai Sixth People's Hospital
2020
Shanghai Jiao Tong University
2020
Wenzhou Medical University
2018-2020
Nanjing Medical University
2015
Magnetic hyperthermia therapy (MHT) has been considered as an excellent alternative for treatment of deep tumor tissue; however, up-regulation heat shock proteins (HSPs) impairs its hyperthermal therapeutic effect. Reactive oxygen species (ROS) and competitive consumption ATP are important targets that can block excessive HSP generation. We developed a magnetic nanocatalytic system comprised glucose oxidase (GOD)-loaded hollow iron oxide nanocatalysts (HIONCs) to drive...
Background Platinum-based chemotherapy is a standard strategy for non-small cell lung cancer (NSCLC), while chemoresistance remains major therapeutic challenge in current clinical practice. Our present study was aimed to determine whether inhibition of the NF-κB/miR-21/PTEN pathway could increase sensitivity NSCLC cisplatin. Methods The expression miR-21 tissues determined using situ hybridization. Next, effect on A549 cells cisplatin vitro. Whether regulated PTEN assessed by luciferase...
Statement of RetractionWe, the Editors and Publisher journal Cell Cycle, have retracted following article:Cheng-Yu Ye, Cui-Ping Zheng, Wei-Wei Ying, Shan-Shan Weng. Up-regulation microRNA-497 inhibits proliferation, migration invasion but increases apoptosis multiple myeloma cells through MAPK/ERK signaling pathway by targeting Raf-1. Cycle. 2018;17(24):2666-2683. doi:10.1080/15384101.2018.1542895.Since publication, significant concerns been raised about integrity data reported results in...
Diffuse large B-cell lymphoma (DLBCL) is a highly aggressive form of non-Hodgkin lymphoma. Long noncoding RNA (lncRNA) has been evaluated as prognostic markers in various carcinomas. However, the value lncRNA index DLBCL not fully understood. Hence, this study aimed to identify olfactory receptor family 2 subfamily A member 1-antisense 1 (OR2A1-AS1) DLBCL.The Gene Expression Omnibus (GEO) database was used obtain GSE97336 dataset comprising expression profiles. Quantitative reverse...